Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης [ Τίτλος(Asc)] Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Hutchings, D. C., Adlam D., Ferreira V., Karamitsos T. D., & Channon K. M. (2011).  Takotsubo cardiomyopathy in association with endogenous and exogenous thyrotoxicosis.. QJM. 104(5), 433-5.
Bossone, E., Lyon A., Citro R., Athanasiadis A., Meimoun P., Parodi G., et al. (2014).  Takotsubo cardiomyopathy: an integrated multi-imaging approach.. Eur Heart J Cardiovasc Imaging. 15(4), 366-77.
Hors-Fraile, S., Schneider F., Fernandez-Luque L., Luna-Perejon F., Civit A., Spachos D., et al. (2018).  Tailoring motivational health messages for smoking cessation using an mHealth recommender system integrated with an electronic health record: a study protocol.. BMC Public Health. 18(1), 698.
Damilakis, J., Prassopoulos P., Mazonakis M., Bizakis J., Papadaki E., & Gourtsoyiannis N. (1998).  Tailored low dose three-dimensional CT of paranasal sinuses.. Clin Imaging. 22(4), 235-9.
Papadopoulos, P., Gutiérrez L., Demmers J., Scheer E., Pourfarzad F., Papageorgiou D. N., et al. (2015).  TAF10 Interacts with the GATA1 Transcription Factor and Controls Mouse Erythropoiesis.. Mol Cell Biol. 35(12), 2103-18.
Giuliano, F., Oelke M., Jungwirth A., Hatzimouratidis K., Watts S., Cox D., et al. (2013).  Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin. J Sex Med. 10(3), 857-65.
Hatzichristou, D., d'Anzeo G., Porst H., Buvat J., Henneges C., Rossi A., et al. (2015).  Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities.. BMC Urol. 15, 111.
Karamouzis, M. V., & Papavassiliou A. G. (2014).  Tackling the cancer signal transduction “labyrinth”: a combinatorial use of biochemical tools with mathematical models will enhance the identification of optimal targets for each molecular defect.. Cancer. 120(3), 316-22.
Mamara, A., Germenis A. E., Kompoti M., Palassopoulou M., Mandala E., Banti A., et al. (2015).  TACI expression and signaling in chronic lymphocytic leukemia.. J Immunol Res. 2015, 478753.
Papazisis, G., Siafis S., & Tzachanis D. (2018).  Tachyphylaxis to the Sedative Action of Mirtazapine.. Am J Case Rep. 19, 410-412.
Geschwind, J-F., Kudo M., Marrero J. A., Venook A. P., Chen X-P., Bronowicki J-P., et al. (2016).  TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.. Radiology. 279(2), 630-40.
Papanikolaou, N., Papadaki E., Karampekios S., Spilioti M., Maris T., Prassopoulos P., et al. (2004).  T2 relaxation time analysis in patients with multiple sclerosis: correlation with magnetization transfer ratio.. Eur Radiol. 14(1), 115-22.
Ferreira, V. M., Piechnik S. K., Dall'Armellina E., Karamitsos T. D., Francis J. M., Ntusi N., et al. (2013).  T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.. JACC Cardiovasc Imaging. 6(10), 1048-58.
Karamitsos, T. D., & Neubauer S. (2015).  T1 mapping and amyloid cardiomyopathy: how much better can it get?. Eur Heart J. 36(4), 203-5.
Tselios, K., Sarantopoulos A., Gkougkourelas I., & Boura P. (2014).  T regulatory cells: a promising new target in atherosclerosis.. Crit Rev Immunol. 34(5), 389-97.
Patas, K., Willing A., Demiralay C., Engler J. Broder, Lupu A., Ramien C., et al. (2018).  T Cell Phenotype and T Cell Receptor Repertoire in Patients with Major Depressive Disorder.. Front Immunol. 9, 291.
S
Papanikolaou, N. A., Tillinger A., Liu X., Papavassiliou A. G., & Sabban E. L. (2014).  A systems approach identifies co-signaling molecules of early growth response 1 transcription factor in immobilization stress.. BMC Syst Biol. 8, 100.
Zachos, I., Konstantinopoulos P. A., Tzortzis V., Gravas S., Karatzas A., Karamouzis M. V., et al. (2010).  Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise.. Expert Opin Investig Drugs. 19(7), 875-87.
Papanikolaou, D., Ioannidou P., Koukourikis P., Moysidis K., Meditskou S., Koutsoumparis D., et al. (2020).  Systemic therapy for chromophobe renal cell carcinoma: A systematic review.. Urol Oncol. 38(4), 137-149.
Dimitroulas, T., Giannakoulas G., Karvounis H., Settas L., & Kitas G. D. (2012).  Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets.. Curr Pharm Des. 18(11), 1457-64.
Psarras, A., Gkougkourelas I., Tselios K., Sarantopoulos A., & Boura P. (2014).  Systemic sclerosis and silicone breast implant: a case report and review of the literature.. Case Rep Rheumatol. 2014, 809629.
Zoccali, C., Vanholder R., Massy Z. A., Ortiz A., Sarafidis P., Dekker F. W., et al. (2017).  The systemic nature of CKD.. Nat Rev Nephrol. 13(6), 344-358.
Mavrogeni, S., Bratis C., Iakovou I., & Kolovou G. (2011).  Systemic lupus erythematosus: two sides of the same coin evaluated by cardiovascular magnetic resonance imaging.. Lupus. 20(12), 1338-9.
Pilalas, D., Chatzopoulos G., Kaiafa G. D., Ztriva E., Spyridonakou S., Bisbinas V., et al. (2019).  Systemic lupus erythematosus in a patient with multiple system atrophy. Medicine. 98(46), e18005.
Tsounis, M., Psillas G., Tsalighopoulos M., Vital V., Maroudias N., & Markou K. (2018).  Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial.. Eur Arch Otorhinolaryngol. 275(1), 103-110.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές